David Lamond - Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
QNCX on Nasdaq
All Insider Reports
All Insider Reports

David Lamond - trading volume in the past year for Quince Therapeutics, Inc.

Holdings reported by David Lamond for Quince Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.35M $2.21M $0.94 Dec 14, 2023 By Blue Devil Trust dated 12/03/2010
Common Stock 2.3M $2.16M $0.94 Dec 12, 2023 Direct
Common Stock 1.73M $1.63M $0.94 Dec 12, 2023 By David A. Lamond Trust dated 2006
Employee Stock Option (right to buy) 27K Jun 5, 2024 Direct Common Stock

Transactions reported by David Lamond for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.